| Trial ID: | L5513 |
| Source ID: | NCT06203275
|
| Associated Drug: |
Paroxetine
|
| Title: |
The G Protein-Coupled Receptor Kinase Type 2 Inhibitor Paroxetine as Adjunctive Therapy to Improve Insulin Sensitivity in Patients With Type 2 Diabetes Mellitus
|
| Acronym: |
|
| Status: |
NOT_YET_RECRUITING
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Diabetes Mellitus, Type 2
|
| Interventions: |
DRUG: Paroxetine|DRUG: Placebo
|
| Outcome Measures: |
Primary: The primary outcome is the change in glycated Hemoglobin (HbA1c)., 3 months|Change in HOMA-IR ., 3 months | Secondary: The secondary outcome is the change in expression of GRK2, 3 months
|
| Sponsor/Collaborators: |
Sponsor: aya ramadan ashmawy sarhan
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE3
|
| Enrollment: |
44
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
|
| Start Date: |
2024-01
|
| Completion Date: |
2026-01
|
| Results First Posted: |
|
| Last Update Posted: |
2024-01-12
|
| Locations: |
|
| URL: |
https://clinicaltrials.gov/show/NCT06203275
|
